Article on safety checks during sterile compounding mentions ISMP's recommendation to avoid reliance on syringe pull-back method for verification, particularly for chemotherapy, complex electrolyte solutions, or compounded sterile products with other high-alert medications.
For the full text, visit Pharmacy Technology Report online. Please note that access may require free registration.
More News
This article appeared on the Drug Topics website on January 18, 2021.
This article appeared on the Becker’s Hospital Review website on January 15, 2021.
This alert appeared on the FDA website on January 15, 2021.